Asia Pacific Radiopharmaceutical Theranostics Market Forecast to 2028 -Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fl

Asia Pacific Radiopharmaceutical Theranostics Market Forecast to 2028-Regional Analysis- by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)


The Asia Pacific radiopharmaceutical theranostics market was valued at US$ 337.53 million in 2022 and is expected to reach US$ 667.40 million by 2028; it is estimated to register a CAGR of 12.0% from 2022 to 2028.

Radiopharmaceutical Theranostics in Nuclear Medicine

Theranostics in nuclear medicine gathers researchers’ interest through molecular imaging and personalized medicine. This is achieved through assistance in the management of various diseases, improves patient selection process, predicts drug response and toxicity, determines prognosis, and helps avoid futile and costly/expensive examinations and treatments. The theranostic approach to nuclear medicine involves a combination of diagnostic imaging and therapy based on a radioactive drug; its primary focus is the diagnosis, while the secondary focus is the treatment of a tumor site. Radioiodine was the first theranostic radiopharmaceutical used in treating and imaging thyroid diseases. In radioiodine therapy, the radioisotope iodine-131 is a gamma and beta emitter, and the sodium-iodide symporter can directly mediate the gamma emitter to thyroid cells. Further, gamma and positron emitters (β+) are used in nuclear imaging. Gamma emitters such as technetium-99m or iodine-123 are used in SPECT imaging, whereas the use of gallium-68 and fluorine-18 in PET imaging can provide better resolution. Therefore, theranostics-based nuclear-targeted therapies are emerging as a useful tool for treating patients suffering from advanced neuroendocrine and gastroenteropancreatic tumors such as neuroblastomas.

Asia Pacific Radiopharmaceutical Theranostics Market Overview

The Asia Pacific radiopharmaceutical theranostics market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share of the market in 2021, and India is expected to exhibit a significant growth pace in the market during the forecast period. The market growth in these countries is attributed to the rising chronic disease prevalence and favorable reimbursement policies. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the radiopharmaceutical theranostics market in the region.

Asia Pacific Radiopharmaceutical Theranostics Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Radiopharmaceutical Theranostics Market Segmentation

The Asia Pacific radiopharmaceutical theranostics market is segmented into product type, radioisotope, source, application, indication, end user, and country. Based on product type, the Asia Pacific radiopharmaceutical theranostics market is segmented into alpha emitters, beta emitters, and positron emission tomography (PET) tracers. The PET tracers segment held the largest market share in 2022.

Based on radioisotope, the Asia Pacific radiopharmaceutical theranostics market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and others. The Lutetium (Lu) 177 segment held the largest market share in 2022.

Based on source, the Asia Pacific radiopharmaceutical theranostics market is bifurcated into nuclear reactors and cyclotrons. The cyclotrons segment held a larger market share in 2022.

Based on application, the Asia Pacific radiopharmaceutical theranostics market is bifurcated into targeted therapeutic (Rx) and Companion Diagnostic (CDx). The targeted therapeutic (Rx) segment held a larger market share in 2022.

Based on indication, the Asia Pacific radiopharmaceutical theranostics market is segmented into oncology, cardiology, neurology, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Asia Pacific radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The oncology segment held the largest market share in 2022.

Based on country, the Asia Pacific radiopharmaceutical theranostics market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radiopharmaceutical theranostics market share in 2022.

Bayer AG, GE Healthcare Technologies Inc., Curium, Telix Pharmaceuticals Ltd., and Cardinal Health Inc. are among the leading companies operating in the Asia Pacific radiopharmaceutical theranostics market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radiopharmaceutical theranostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radiopharmaceutical theranostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radiopharmaceutical theranostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Radiopharmaceutical Theranostics Market - by Product Type
1.3.2 Asia Pacific Radiopharmaceutical Theranostics Market - by Radioisotope
1.3.3 Asia Pacific Radiopharmaceutical Theranostics Market - by Source
1.3.4 Asia Pacific Radiopharmaceutical Theranostics Market - by Application
1.3.5 Asia Pacific Radiopharmaceutical Theranostics Market - by Indication
1.3.6 Asia Pacific Radiopharmaceutical Theranostics Market - by End User
1.3.7 Asia Pacific Radiopharmaceutical Theranostics Market - by Country
2. Radiopharmaceutical Theranostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Radiopharmaceutical Theranostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. Asia Pacific Radiopharmaceutical Theranostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis
6. Radiopharmaceutical Theranostics Market - Asia Pacific Analysis
6.1 Asia Pacific Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
7. Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Product Type
7.1 Overview
7.2 Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
7.2.1 Positron Emission Tomography (PET) Tracers
7.2.1.1 Overview
7.2.1.2 Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
7.2.2 Beta Emitters
7.2.2.1 Overview
7.2.2.2 Beta Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
7.2.3 Alpha Emitters
7.2.3.1 Overview
7.2.3.2 Alpha Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Radiopharmaceutical Theranostics Market Analysis - by Radioisotope
8.1 Overview
8.2 Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
8.2.1 Technetium-99
8.2.1.1 Overview
8.2.1.2 Technetium-99: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.2 Gallium-68
8.2.2.1 Overview
8.2.2.2 Gallium-68: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.3 Iodine-131
8.2.3.1 Overview
8.2.3.2 Iodine-131: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.4 Iodine-123
8.2.4.1 Overview
8.2.4.2 Iodine-123: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.5 Fluorine-18 (18F)
8.2.5.1 Overview
8.2.5.2 Fluorine-18 (18F): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.6 Yttrium 90 (Y-90)
8.2.6.1 Overview
8.2.6.2 Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.7 Lutetium (LU) 177
8.2.7.1 Overview
8.2.7.2 Lutetium (LU) 177: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.8 Copper (CU) 67
8.2.8.1 Overview
8.2.8.2 Copper (CU) 67: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.9 Copper (CU) 64
8.2.9.1 Overview
8.2.9.2 Copper (CU) 64: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
8.2.10 Others
8.2.10.1 Overview
8.2.10.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Radiopharmaceutical Theranostics Market Analysis - by Source
9.1 Overview
9.2 Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
9.2.1 Nuclear Reactors
9.2.1.1 Overview
9.2.1.2 Nuclear Reactors: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.2 Cyclotrons
9.2.2.1 Overview
9.2.2.2 Cyclotrons: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Radiopharmaceutical Theranostics Market Analysis - by Application
10.1 Overview
10.2 Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
10.2.1 Targeted Therapeutic (Rx)
10.2.1.1 Overview
10.2.1.2 Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.2 Companion Diagnostic (CDx)
10.2.2.1 Overview
10.2.2.2 Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11. Asia Pacific Radiopharmaceutical Theranostics Market Analysis - by Indication
11.1 Overview
11.2 Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
11.2.1 Oncology
11.2.1.1 Overview
11.2.1.2 Oncology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.2 Neurology
11.2.2.1 Overview
11.2.2.2 Neurology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Cardiology
11.2.3.1 Overview
11.2.3.2 Cardiology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
11.2.4 Others
11.2.4.1 Overview
11.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12. Asia Pacific Radiopharmaceutical Theranostics Market Analysis - by End User
12.1 Overview
12.2 Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
12.2.1 Hospitals
12.2.1.1 Overview
12.2.1.2 Hospitals: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12.2.2 Diagnostic Imaging Centers
12.2.2.1 Overview
12.2.2.2 Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12.2.3 Academic & Research Institutes
12.2.3.1 Overview
12.2.3.2 Academic & Research Institutes: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
12.2.4 Others
12.2.4.1 Overview
12.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13. Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Country Analysis
13.1 Asia Pacific: Radiopharmaceutical Theranostics Market
13.1.1 Overview
13.1.2 Asia Pacific: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 China: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 China: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 China Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.1.4 China Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.1.5 China Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.1.6 China Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.1.7 China Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.1.8 China Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.2 Japan: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 Japan: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 Japan Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.2.4 Japan Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.2.5 Japan Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.2.6 Japan Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.2.7 Japan Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.2.8 Japan Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.3 India: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 India: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 India Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.3.4 India Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.3.5 India Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.3.6 India Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.3.7 India Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.3.8 India Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.4 South Korea: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.1 Overview
13.1.2.4.2 South Korea: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.3 South Korea Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.4.4 South Korea Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.4.5 South Korea Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.4.6 South Korea Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.4.7 South Korea Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.4.8 South Korea Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.5 Australia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.1 Overview
13.1.2.5.2 Australia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.3 Australia Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.5.4 Australia Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.5.5 Australia Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.5.6 Australia Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.5.7 Australia Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.5.8 Australia Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
13.1.2.6 Rest of Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.1 Overview
13.1.2.6.2 Rest of Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.3 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
13.1.2.6.4 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
13.1.2.6.5 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
13.1.2.6.6 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
13.1.2.6.7 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
13.1.2.6.8 Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
14. Radiopharmaceutical Theranostics Market - Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 Bayer AG
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 GE HealthCare Technologies Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Curium
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Telix Pharmaceuticals Ltd.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Cardinal Health Inc
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. China Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. China Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 3. China Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 4. China Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. China Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 6. China Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. India Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. India Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 15. India Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 16. India Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. India Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 18. India Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 21. South Korea Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 22. South Korea Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. South Korea Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 24. South Korea Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Australia Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 26. Australia Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 27. Australia Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 28. Australia Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 29. Australia Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 30. Australia Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia Pacific Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 38. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
Table 39. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Radiopharmaceutical Theranostics Market Segmentation
Figure 2. Asia Pacific Radiopharmaceutical Theranostics Market, by Country
Figure 3. Asia Pacific Radiopharmaceutical Theranostics Market Overview
Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
Figure 5. India Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Asia Pacific Experts’ Opinion
Figure 8. Asia Pacific Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Radiopharmaceutical Theranostics Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Asia Pacific Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
Figure 11. Positron Emission Tomography (PET) Tracers: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Beta Emitters: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Alpha Emitters: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
Figure 15. Technetium-99: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Gallium-68: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Iodine-131: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Iodine-123: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Fluorine-18 (18F): Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Yttrium 90 (Y-90): Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Lutetium (LU) 177: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Copper (CU) 67: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Copper (CU) 64: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
Figure 26. Nuclear Reactors: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cyclotrons: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Asia Pacific Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
Figure 29. Targeted Therapeutics (Rx): Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Companion Diagnostics (CDx): Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Asia Pacific Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
Figure 32. Oncology: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Neurology: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Cardiology: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Asia Pacific Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
Figure 37. Hospitals: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Diagnostic Imaging Centers: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Academic & Research Institutes: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Others: Asia Pacific Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Asia Pacific: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 42. China: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Japan: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. India: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. South Korea: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Australia: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Asia Pacific: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Growth Strategies in the Radiopharmaceutical Theranostics Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings